The Powell Perspective

C&S Wholesale Grocers' deep price cuts offer shoppers relief, but behind the bargains lies a strategic gambit that could reshape the Midwest's competitive landscape.

OPAL Fuels is set to report Q2 earnings on Aug 10. Amid volatile RIN prices and new EPA rules, investors will scrutinize production growth and profitability.

Bregal Sagemount's majority stake in ATOZ Services isn't just a deal; it's a bet on AI and M&A reshaping the multi-trillion-dollar fund administration industry.

Texas Capital Bancshares reports a stellar Q2 with record fee income and 10% profit growth. Yet, a closer look reveals a troubling rise in criticized loans.

As data centers and electrification strain the national grid, one company is turning millions of square feet of warehouse roofs into a new class of power plant.

With 61% of its students being the first in their families to attend college, Goodwin's new initiatives offer more than support—they offer a national blueprint.

A new partnership between Evogene and ELEO leverages AI and natural product science to create an oral PCSK9 inhibitor, aiming to disrupt a $23B market.

The carrier's investment in the SAFFA Fund is a crucial step, but the path to decarbonizing aviation is fraught with production gaps and economic hurdles.

Linxup’s new rear cameras highlight a critical trend: comprehensive visibility is no longer a luxury for fleets, but a vital tool for managing liability and ROI.

At AIDS 2026, ViiV Healthcare unveils data challenging treatment norms, proving long-acting injectable efficacy, and paving the way for quarterly PrEP.

Amid record office vacancies, a 54,000 sq-ft lease at the iconic Transamerica Complex signals a strategic wager on the future of premium, flexible work.

Lundbeck completes enrollment for a pivotal trial testing a novel drug for severe childhood epilepsies. But what are the real stakes for patients and investors?

UAE's e& banks $5.95B from its Vodafone sale, refocusing on core assets. But as one giant exits, French telecom tycoon Xavier Niel enters the fray.

As PPL prepares its Q2 earnings, the utility stands at a crossroads of massive grid investment, soaring data center demand, and customer affordability.

Riverbed's recent industry nod isn't just a win; it's a signal. The age of autonomous IT is here, but its success hinges on one critical element: control.

A groundbreaking NEJM report shows Neutrolis's therapy rapidly reversed severe Lupus symptoms, validating a new, non-immunosuppressive approach.

Unlimited ETFs' AI-driven funds are posting top-tier returns, pulling in over $225M. But is this the future of accessible alts or a high-risk tech gambit?

A massive Texas expansion by Race Rock signals a critical shift. The private firm is betting on the urgent need to modernize North America's aging energy grid.

Conagra Brands slashed its dividend by 50%, calling it a 'reset.' We dissect if this is a prudent move to fund growth or a red flag for investors.

A new hospital designation promises safer surgical care for older adults. But what are the hidden costs for hospitals, and will it truly empower patients?